Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C70H92ClN17O14 |
Molecular Weight | 1431.038 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC2=CN=CC=C2)NC(=O)[C@@H](CC3=CC=C(Cl)C=C3)NC(=O)[C@@H](CC4=CC5=CC=CC=C5C=C4)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N6CCC[C@H]6C(=O)N[C@H](C)C(N)=O
InChI
InChIKey=SBNPWPIBESPSIF-MHWMIDJBSA-N
InChI=1S/C70H92ClN17O14/c1-39(2)31-52(61(94)82-51(15-9-28-77-69(73)74)68(101)88-30-10-16-58(88)67(100)79-40(3)59(72)92)83-60(93)50(14-8-29-78-70(75)102)81-63(96)54(34-43-20-25-49(91)26-21-43)86-66(99)57(38-89)87-65(98)56(36-45-11-7-27-76-37-45)85-64(97)55(33-42-18-23-48(71)24-19-42)84-62(95)53(80-41(4)90)35-44-17-22-46-12-5-6-13-47(46)32-44/h5-7,11-13,17-27,32,37,39-40,50-58,89,91H,8-10,14-16,28-31,33-36,38H2,1-4H3,(H2,72,92)(H,79,100)(H,80,90)(H,81,96)(H,82,94)(H,83,93)(H,84,95)(H,85,97)(H,86,99)(H,87,98)(H4,73,74,77)(H3,75,78,102)/t40-,50-,51+,52+,53-,54+,55-,56-,57+,58+/m1/s1
Molecular Formula | C70H92ClN17O14 |
Molecular Weight | 1431.038 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 3 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:32:31 UTC 2023
by
admin
on
Fri Dec 15 15:32:31 UTC 2023
|
Record UNII |
OON1HFZ4BA
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175839
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
||
|
NCI_THESAURUS |
C2092
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
||
|
NDF-RT |
N0000175084
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
||
|
WHO-VATC |
QH01CC02
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
||
|
WHO-ATC |
H01CC02
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
CETROTIDE (AUTHORIZED: OVULATION INDUCTION)
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
||
|
NDF-RT |
N0000008638
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL1200490
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | |||
|
DB00050
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | |||
|
OON1HFZ4BA
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | |||
|
120287-85-6
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | |||
|
6661
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | |||
|
59224
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | |||
|
100000085454
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | |||
|
C2481
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | |||
|
25074887
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | |||
|
SUB07459MIG
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | |||
|
1190
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | |||
|
CETRORELIX
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | |||
|
583
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | |||
|
m3295
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | Merck Index | ||
|
68147
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | RxNorm | ||
|
OON1HFZ4BA
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | |||
|
DTXSID7040996
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY | |||
|
7696
Created by
admin on Fri Dec 15 15:32:31 UTC 2023 , Edited by admin on Fri Dec 15 15:32:31 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
BINDER->LIGAND |
BINDING
|
||
|
EXCRETED UNCHANGED |
AMOUNT EXCRETED
URINE
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
SUBCUTANEOUS ADMINISTRATION |
|
||
Tmax | PHARMACOKINETIC |
|
SINGLE DOSE |
|
||
Biological Half-life | PHARMACOKINETIC |
|
SUBCUTANEOUS ADMINISTRATION |
|
||